Clinical Decision Support Tool for Chronic Kidney Disease

(PROMPT-CKD Trial)

FP
Overseen ByFrancis P Wilson, MD MSCE
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Yale University
Must be taking: ACEi/ARB, SGLT2i, MRA, GLP-1 RA
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is a cluster-randomized clinical trial to evaluate whether a tailored, user-centered, clinical decision support (CDS) tool can positively influence prescriber behavior and increase prescription of guideline-directed medical therapy (GDMT) among patients with Chronic Kidney Disease (CKD) across a single healthcare center.

Who Is on the Research Team?

FP

Francis P Wilson, MD MSCE

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

Inclusion Criteria

I have type 2 diabetes.
I am able to swallow and take pills by mouth.
I am 18 years old or older.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

Immediate upon opening order entry screen

Treatment

Providers are exposed to a clinical decision support tool to influence prescription behavior for CKD treatment

90 days

Follow-up

Participants are monitored for safety and effectiveness after treatment, including time to new GDMT prescription and other secondary outcomes

365 days

What Are the Treatments Tested in This Trial?

Interventions

  • Best practice alert and order set for CKD

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Exposure to clinical decision support toolExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+